Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 1038-1047
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1038
Figure 1
Figure 1 Fecal hemoglobin (ng/mL) according to the most advanced lesion. Values expressed as mean ± SD. Mann-Withney test. FIT: Fecal immunochemical test; FIT1: Fecal hemoglogin concentration in the first stool sample; FITmax: Highest fecal hemoglobin concentration of two stool samples.
Figure 2
Figure 2 Receiver operating characteristics curves of fecal immunochemical test-1 and -max for advanced neoplasia and invasive cancer. FIT: Fecal immunochemical test; FIT1: Fecal hemoglogin concentration in the first stool sample; FITmax: Highest fecal hemoglobin concentration of two stool samples; AUC: Area under the curve. 1P = 0.034 with respect to FITmax in the homogeneity area test.

  • Citation: Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, investigators JIRPTCS. Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol 2014; 20(4): 1038-1047
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i4/1038.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i4.1038